Skip to main content

Advertisement

Table 3 Univariate and multivariate analysis of No.10/11LN metastasis for 152 advanced proximal gastric cancer patients who underwent curative gastrectomy with splenectomy or pancreatectomy

From: Risk evaluation of splenic hilar or splenic artery lymph node metastasis and survival analysis for patients with proximal gastric cancer after curative gastrectomy: a retrospective study

  Univariate analysis Multivariate analysis
No.10/11 - No.10/11+ P a RR 95%CI P b
No.1/3
 - 91 (77.1%) 27 (22.9%)     
 + 17 (50.0%) 17 (55.0%) 0.002 1.162 0.374–3.616 0.795
No.2/4
 - 84 (89.4%) 10 (10.6%)     
 + 24 (41.4%) 34 (58.6%) < 0.001 6.780 2.316–19.846 < 0.001
No. 5
 - 97 (72.9%) 36 (27.1%)     
 + 11 (57.9%) 8 (42.1%) 0.176    
No.6
 - 94 (74.6%) 32 (25.4%)     
 + 14 (53.8%) 12 (46.2%) 0.034 2.615 0.735–9.306 0.138
No.7
 - 93 (78.8%) 25 (21.2%)     
 + 15 (44.1%) 19 (55.9%) < 0.001 2.483 0.811–7.602 0.111
No.8
 - 99 (75.0%) 33 (25.0%)     
 + 9 (45.0%) 11 (55.0%) 0.006 1.869 0.469–7.454 0.376
No. 9
 - 106 (75.2%) 35 (24.8%)     
 + 2 (18.2%) 9 (81.8%) < 0.001 3.338 1.249–3.595 0.202
No. 12a
 - 100 (71.4%) 40 (28.6%)     
 + 8 (66.7%) 4 (33.3%) 0.727    
Tumor size
  < 5 cm 27 (71.1%) 11 (28.9%)     
 5-10 cm 64 (72.7%) 24 (27.3%)     
  ≥ 10 cm 17 (65.4%) 9 (34.6%) 0.769    
Bormann type
 Bor 1–2 28 (82.4%) 6 (17.6%)     
 Bor 3 68 (73.1%) 25 (26.9%)   1.117 0.318–3.919 0.863
 Bor 4 12 (48.0%) 13 (52.0%) 0.013 2.126 0.417–10.846 0.365
Serosa involved
 No 29 (80.6%) 7 (19.4%)     
 Yes 79 (68.1%) 37 (31.9%) 0.150    
Differentiation
 Well 55 (80.9%) 13 (19.1%)     
 Poor 53 (63.1%) 31 (36.9%) 0.016 1.313 0.465–3.707 0.607
Greater curvature involved
 No 75 (82.4%) 16 (17.6%)     
 Yes 33 (54.1%) 28 (45.9%) < 0.001 2.963 1.112–7.897 0.030
  1. a:χ2test, b:Logistic regression method used on variables identified as significant by univariate analysis
  2. +, positive for the lymph node metastasis; −, negative for the lymph node metastasis